SCHEMBL8966189

SCHEMBL8966189

COc1cc(C=Cc2ccc(=O)[nH]n2)cc(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.63
▸ NPC1 O15118 2/20 0.63
▸ RAB9A P51151 2/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ PTGS1 P23219 2/20 0.60
▸ PTGS2 P35354 2/20 0.60
▸ KDM4E B2RXH2 3/20 0.56
▸ CYP1A2 P05177 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ POLB P06746 2/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ TUBB4A P04350 7/20 0.56
▸ TUBB P07437 7/20 0.56
▸ TUBA3C P0DPH7 7/20 0.56
▸ TUBA1B P68363 7/20 0.56
▸ TUBA4A P68366 7/20 0.56
▸ TUBB4B P68371 7/20 0.56
▸ TUBB3 Q13509 7/20 0.56
▸ TUBB2A Q13885 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10761840 1.00 LMNA (0.63) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10764067 0.89 LMNA (0.54) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10763628 0.89 LMNA (0.54) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10764071 0.89 LMNA (0.54) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10763622 0.89 LMNA (0.54) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10762871 0.87 LMNA (0.52) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10762880 0.87 LMNA (0.52) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10764099 0.86 LMNA (0.68) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10764094 0.86 LMNA (0.68) LMNANPC1RAB9ASMN1; SMN2PTGS1
SCHEMBL10762714 0.85 LMNA (0.59) LMNANPC1RAB9ASMN1; SMN2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538970-A Treatment of cancer with imidazo-1,2-pyridazin compounds GLAXO WELLCOME INC. (US) 1996-07-23 — — US disclosed
US-5447956-A Anticarcinogenic agents BURROUGHS WELLCOME CO. (US) 1995-09-05 — — US disclosed
US-5380759-A Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia BURROUGHS WELLCOME CO. (US) 1995-01-10 — — US disclosed
US-5371219-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1994-12-06 — — US disclosed
EP-0305093-B1 Imidazo(1,2-b)pyridazine derivatives WELLCOME FOUND (GB) 1994-04-06 — — EP disclosed
US-5091531-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1992-02-25 — — US disclosed
EP-0305093-A1 Imidazo(1,2-b)pyridazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1989-03-01 — — EP disclosed
EP-0210530-A1 6-Arylalkenyl pyridazinones MERCK PATENT GmbH (DE) 1987-02-04 — — EP disclosed
Send feedback